Listed

Immuron Ltd

IMRNNasdaqCIK 1660046HealthcareFiscal year ends Jun 30

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$2.7m, FY2024
Line itemUnitFY20232023-06-30FY20242024-06-30
Cash and equivalents$k4,771Cash and equivalents, FY2023, at 2023-06-30$4.8m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-10-01, accession 0001213900-24-083654.Report this figure2,722Cash and equivalents, FY2024, at 2024-06-30$2.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-10-01, accession 0001213900-24-083654.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.